BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2927136)

  • 1. Optimal debulking following chemotherapy of advanced-stage epithelial ovarian carcinoma.
    Piura B; Glezerman M
    J Surg Oncol; 1989 Apr; 40(4):237-40. PubMed ID: 2927136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
    Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
    Sun T; Feng Y; Zhu Y; Zheng Y
    Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early debulking surgery after chemotherapy in advanced cancer of the ovary].
    de Gramont A; Pigné A; Louvet C; Sezeur A; Marpeau L; Vaillant JC; Cady J; Varette C; Demuynck B; Couturier JY; Lagadec B; Milliez J; Barrat J; Krulik M
    Ann Chir; 1997; 51(10):1069-76. PubMed ID: 10868028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
    Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
    J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
    Jacob JH; Gershenson DM; Morris M; Copeland LJ; Burke TW; Wharton JT
    Gynecol Oncol; 1991 Aug; 42(2):146-50. PubMed ID: 1894174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of epithelial cancers of the ovary in advanced stages with surgery and cisplatin chemotherapy].
    Dauplat J; Ferrière JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
    Presse Med; 1986 Sep; 15(29):1351-4. PubMed ID: 2950408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal debulking surgery followed by paclitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience.
    Chun KC; Kim JJ; Kim DY; Kim JH; Kim YM; Nam JH; Kim YT
    Gynecol Obstet Invest; 2011; 72(3):208-14. PubMed ID: 21968161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
    Bian C; Yao K; Li L; Yi T; Zhao X
    Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
    Lawton FG; Redman CW; Luesley DM; Chan KK; Blackledge G
    Obstet Gynecol; 1989 Jan; 73(1):61-5. PubMed ID: 2462202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
    Huober J; Meyer A; Wagner U; Wallwiener D
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
    Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
    Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-look laparotomy in managing epithelial ovarian carcinoma.
    Dauplat J; Ferriere JP; Gorbinet M; Legros M; Chollet P; Giraud B; Plagne R
    Cancer; 1986 Apr; 57(8):1627-31. PubMed ID: 3948133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look laparotomy in ovarian carcinoma patients after 8 and after 12 courses of cisplatin-based chemotherapy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Gynecol Obstet Invest; 1989; 27(2):102-4. PubMed ID: 2731767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
    Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients.
    de Gramont A; Drolet Y; Varette C; Louvet C; Gonzalez-Canall G; Krulik M; Cady J; Pigne A; Marpeau L; Barrat J
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):451-7. PubMed ID: 2702999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    de Gramont A; Demuynck B; Varette C; Louvet C; Pigne A; Marpeau L; Lagadec B; Cady J; Couturier JY; Delfau S
    Eur J Cancer; 1992; 28(1):53-8. PubMed ID: 1567692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
    Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H
    Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.